Literature DB >> 32277901

Outpatient management of alcohol-related liver disease.

Douglas A Simonetto1, Vijay H Shah1, Patrick S Kamath2.   

Abstract

Alcohol-related liver disease has become the leading indication for liver transplantation in the USA, partly due to an increase in the prevalence of high-risk drinking behaviour and alcohol use disorder, particularly among young women. Achieving sustained alcohol abstinence might not only prevent the development and progression of alcohol-related liver disease, but could also lead to clinically significant improvements, even in the advanced stages of disease. In this Series paper, we discuss the diagnosis and outpatient management of alcohol-related liver disease, with an emphasis on treatment options for alcohol use disorder and the assessment of nutritional status.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32277901      PMCID: PMC8074849          DOI: 10.1016/S2468-1253(19)30415-7

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


  80 in total

1.  The high burden of alcoholic cirrhosis in privately insured persons in the United States.

Authors:  Jessica L Mellinger; Kerby Shedden; Gerald Scott Winder; Elliot Tapper; Megan Adams; Robert J Fontana; Michael L Volk; Frederic C Blow; Anna S F Lok
Journal:  Hepatology       Date:  2018-05-20       Impact factor: 17.425

2.  Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis.

Authors:  Eric Nguyen-Khac; Maja Thiele; Cosmin Voican; Pierre Nahon; Christophe Moreno; Jerome Boursier; Sebastian Mueller; Victor de Ledinghen; Peter Stärkel; Sang Gyune Kim; Michael Fernandez; Bjorn Madsen; Sylvie Naveau; Aleksander Krag; Gabriel Perlemuter; Marianne Ziol; Denis Chatelain; Momar Diouf
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-07-06

Review 3.  The stigma of alcohol dependence compared with other mental disorders: a review of population studies.

Authors:  Georg Schomerus; Michael Lucht; Anita Holzinger; Herbert Matschinger; Mauro G Carta; Matthias C Angermeyer
Journal:  Alcohol Alcohol       Date:  2010-12-18       Impact factor: 2.826

4.  Utility of a new model to diagnose an alcohol basis for steatohepatitis.

Authors:  Winston Dunn; Paul Angulo; Schuyler Sanderson; Laith H Jamil; Linda Stadheim; Charles Rosen; Michael Malinchoc; Patrick S Kamath; Vijay H Shah
Journal:  Gastroenterology       Date:  2006-08-10       Impact factor: 22.682

5.  Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013: Results From the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Bridget F Grant; S Patricia Chou; Tulshi D Saha; Roger P Pickering; Bradley T Kerridge; W June Ruan; Boji Huang; Jeesun Jung; Haitao Zhang; Amy Fan; Deborah S Hasin
Journal:  JAMA Psychiatry       Date:  2017-09-01       Impact factor: 21.596

6.  The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.

Authors:  D Sorbi; J Boynton; K D Lindor
Journal:  Am J Gastroenterol       Date:  1999-04       Impact factor: 10.864

Review 7.  The Prevalence of Metabolic Syndrome in Alcohol Use Disorders: A Systematic Review and Meta-analysis.

Authors:  Davy Vancampfort; Mats Hallgren; James Mugisha; Marc De Hert; Michel Probst; Dirk Monsieur; Brendon Stubbs
Journal:  Alcohol Alcohol       Date:  2016-06-23       Impact factor: 2.826

8.  Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.

Authors:  Donghee Kim; Andrew A Li; Chiranjeevi Gadiparthi; Muhammad Ali Khan; George Cholankeril; Jeffrey S Glenn; Aijaz Ahmed
Journal:  Gastroenterology       Date:  2018-09-01       Impact factor: 22.682

9.  Zinc supplementation in patients with cirrhosis and hepatic encephalopathy: a systematic review and meta-analysis.

Authors:  Ying-Chi Shen; Ya-Hui Chang; Ching-Ju Fang; Yang-Sheng Lin
Journal:  Nutr J       Date:  2019-07-06       Impact factor: 3.271

10.  A Model to Identify Sarcopenia in Patients With Cirrhosis.

Authors:  Puneeta Tandon; Gavin Low; Marina Mourtzakis; Laura Zenith; Robert P Myers; Juan G Abraldes; Abdel Aziz M Shaheen; Hina Qamar; Nadia Mansoor; Michelle Carbonneau; Kathleen Ismond; Sumeer Mann; Alshimaa Alaboudy; Mang Ma
Journal:  Clin Gastroenterol Hepatol       Date:  2016-05-14       Impact factor: 11.382

View more
  4 in total

Review 1.  Current Medical Treatment for Alcohol-Associated Liver Disease.

Authors:  Gustavo Ayares; Francisco Idalsoaga; Luis A Díaz; Jorge Arnold; Juan P Arab
Journal:  J Clin Exp Hepatol       Date:  2022-02-12

2.  Hepatoprotective Mechanism of Ginsenoside Rg1 against Alcoholic Liver Damage Based on Gut Microbiota and Network Pharmacology.

Authors:  Ting Xia; Bin Fang; Chaoyan Kang; Yuxuan Zhao; Xiao Qiang; Xiaodong Zhang; Yiming Wang; Tian Zhong; Jianbo Xiao; Min Wang
Journal:  Oxid Med Cell Longev       Date:  2022-08-23       Impact factor: 7.310

3.  Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA).

Authors:  Gianni Testino; Teo Vignoli; Valentino Patussi; Pierluigi Allosio; Maria Francesca Amendola; Sarino Aricò; Aniello Baselice; Patrizia Balbinot; Vito Campanile; Tiziana Fanucchi; Giovanni Greco; Livia Macciò; Cristina Meneguzzi; Davide Mioni; Vincenzo Ostilio Palmieri; Michele Parisi; Doda Renzetti; Raffaella Rossin; Claudia Gandin; Luigi Carlo Bottaro; Mauro Bernardi; Giovanni Addolorato; Lisa Lungaro; Giorgio Zoli; Emanuele Scafato; Fabio Caputo
Journal:  Dig Dis Sci       Date:  2021-06-17       Impact factor: 3.487

Review 4.  Moderate Alcoholic Hepatitis.

Authors:  Ana Clemente-Sánchez; Aline Oliveira-Mello; Ramón Bataller
Journal:  Clin Liver Dis       Date:  2021-05-27       Impact factor: 6.265

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.